ALEXANDRIA, Va., June 19 -- United States Patent no. 12,335,342, issued on June 17, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).
"Transmitting analyte data using low-power instruction sets" was invented by Xuandong Hua (Mountain View, Calif.), Yongjian Wu (Saratoga, Calif.) and Danny Chan (Daly City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments described herein include an analyte monitoring device. The analyte monitoring device generates sensor data indicative of an analyte level measured by an analyte sensor transcutaneously positioned in contact with a bodily fluid of the subject. The analyte monitoring device initializes a communication module using an advertisement sc...